National clinical practice guidelines for allergen immunotherapy: An international assessment applying <scp>AGREE</scp>‐<scp>II</scp>

Abstract

We here evaluate allergen immunotherapy guideline (AIT-GL) quality. Only high-quality AIT-GLs should be consulted for AIT management decisions. In low-resource settings, transculturization of these is preferred over developing low-quality guidelines.